View Item 

Show simple item record

Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis–Associated Interstitial Lung Disease

dc.contributor.authorYang, Monica M.
dc.contributor.authorBalmert, Lauren C.
dc.contributor.authorMarangoni, Roberta Goncalves
dc.contributor.authorCarns, Mary
dc.contributor.authorHinchcliff, Monique
dc.contributor.authorKorman, Benjamin D.
dc.contributor.authorVarga, John
dc.date.accessioned2023-01-11T16:23:27Z
dc.date.available2024-02-11 11:23:25en
dc.date.available2023-01-11T16:23:27Z
dc.date.issued2023-01
dc.identifier.citationYang, Monica M.; Balmert, Lauren C.; Marangoni, Roberta Goncalves; Carns, Mary; Hinchcliff, Monique; Korman, Benjamin D.; Varga, John (2023). "Circulating CTRP9 Is Associated With Severity of Systemic Sclerosis–Associated Interstitial Lung Disease." Arthritis Care & Research 75(1): 152-157.
dc.identifier.issn2151-464X
dc.identifier.issn2151-4658
dc.identifier.urihttps://hdl.handle.net/2027.42/175437
dc.publisherWiley Periodicals, Inc.
dc.titleCirculating CTRP9 Is Associated With Severity of Systemic Sclerosis–Associated Interstitial Lung Disease
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGeriatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175437/1/acr24749-sup-0001-Disclosureform.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175437/2/acr24749_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175437/3/acr24749.pdf
dc.identifier.doi10.1002/acr.24749
dc.identifier.sourceArthritis Care & Research
dc.identifier.citedreferencePeterson JM, Wei Z, Seldin MM, et al. CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. Am J Physiol Regul Integr Comp Physiol 2013; 305: R522 – 33.
dc.identifier.citedreferenceMisharin AV, Morales-Nebreda L, Reyfman PA, et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J Exp Med 2017; 214: 2387 – 404.
dc.identifier.citedreferenceMarangoni RG, Korman BD, Wei J, et al. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors. Arthritis Rheumatol 2015; 67: 1062 – 73.
dc.identifier.citedreferenceLakota K, Wei J, Carns M, et al. Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? Arthritis Res Ther 2012; 14: R102.
dc.identifier.citedreferenceZhao JH, Huang XL, Duan Y, et al. Serum adipokines levels in patients with systemic sclerosis: a meta-analysis. Mod Rheumatol 2017; 27: 298 – 305.
dc.identifier.citedreferenceKorman B, Alejo R, Sudhakar D, et al. The novel adipokine C1q-TNF related protein 9 (CTRP9) is elevated in systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol 2018; 36 Suppl 113: 184 – 5.
dc.identifier.citedreferenceVan den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737 – 47.
dc.identifier.citedreferenceGoh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177: 1248 – 54.
dc.identifier.citedreferenceCaron M, Hoa S, Hudson M, et al. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev Off J Eur Respir Soc 2018; 27.
dc.identifier.citedreferenceScott MK, Quinn K, Li Q, et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir Med 2019; 7: 497 – 508.
dc.identifier.citedreferenceJones BL, Nagin DS. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res 2007; 35: 542 – 71.
dc.identifier.citedreferenceJones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res 2001; 29: 374 – 93.
dc.identifier.citedreferenceKafaja S, Clements PJ, Wilhalme H, et al. Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung Studies (SLS-I and SLS-II). Am J Respir Crit Care Med 2018; 197: 644 – 52.
dc.identifier.citedreferenceBudulgan M, Dilek B, Dağ ŞB, et al. Relationship between serum leptin level and disease activity in patients with systemic sclerosis. Clin Rheumatol 2014; 33: 335 – 9.
dc.identifier.citedreferenceNeumann E, Lepper N, Vasile M, et al. Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement. Cytokine 2019; 117: 41 – 9.
dc.identifier.citedreferenceWong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. FASEB J Off Publ Fed Am Soc Exp Biol 2009; 23: 241 – 58.
dc.identifier.citedreferenceMoradi N, Fadaei R, Emamgholipour S, et al. Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery disease. PloS One 2018; 13: e0192159.
dc.identifier.citedreferenceTyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809 – 15.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acr24749-sup-0001-Disclosurefo ...
Size:
401.1KB
Format:
PDF
View/Open
Name:
acr24749_am.pdf
Size:
876.2KB
Format:
PDF
View/Open
Name:
acr24749.pdf
Size:
1.525MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.